More support needed for UK innovation
Criticised pricing policies
In the third part of a short series, managers tell Investment Week which value plays still look attractive after a strong run this year.
Tides change for India and China
2016 saw several blow-ups for large drug companies
New products, strong finances and robust growth were the main talking points at JP Morgan's recent healthcare conference in San Francisco. There were positive signals regarding the fundraising climate, as well as the strength of innovation within the...
Opportunities in a number of sectors